Effects of empagliflozin on markers of calcium and phosphate homeostasis in patients with type 2 diabetes – Data from a randomized, placebo-controlled study

por Rau, Matthias, Thiele, Kirsten, Hartmann, Niels-Ulrik Korbinian, Möllmann, Julia, Wied, Stephanie, Hohl, Mathias, Marx, Nikolaus, Lehrke, Michael
Publicado 2022

Empagliflozin does not change cardiac index nor systemic vascular resistance but rapidly improves left ventricular filling pressure in patients with type 2 diabetes: a randomized c...

por Rau, Matthias, Thiele, Kirsten, Hartmann, Niels-Ulrik Korbinian, Schuh, Alexander, Altiok, Ertunc, Möllmann, Julia, Keszei, András P., Böhm, Michael, Marx, Nikolaus, Lehrke, Michael
Publicado 2021

Glycaemic variability is associated with all-cause mortality in COVID-19 patients with ARDS, a retrospective subcohort study

por Hartmann, Bojan, Verket, Marlo, Balfanz, Paul, Hartmann, Niels-Ulrik, Jacobsen, Malte, Brandts, Julia, Dreher, Michael, Kossack, Nils, Häckl, Dennis, Marx, Nikolaus, Müller-Wieland, Dirk
Publicado 2022

Empagliflozin reduces markers of acute kidney injury in patients with acute decompensated heart failure

por Thiele, Kirsten, Rau, Matthias, Hartmann, Niels‐Ulrik Korbinian, Möller, Marcus, Möllmann, Julia, Jankowski, Joachim, Keszei, András P., Böhm, Michael, Floege, Jürgen, Marx, Nikolaus, Lehrke, Michael
Publicado 2022

Long COVID‐19: Objectifying most self‐reported neurological symptoms

por Bungenberg, Julia, Humkamp, Karen, Hohenfeld, Christian, Rust, Marcus Immanuel, Ermis, Ummehan, Dreher, Michael, Hartmann, Niels‐Ulrik Korbinian, Marx, Gernot, Binkofski, Ferdinand, Finke, Carsten, Schulz, Jörg B., Costa, Ana Sofia, Reetz, Kathrin
Publicado 2022

Six Months Follow-Up of Patients with Invasive Mechanical Ventilation Due to COVID-19 Related ARDS

por Daher, Ayham, Cornelissen, Christian, Hartmann, Niels-Ulrik, Balfanz, Paul, Müller, Annegret, Bergs, Ingmar, Aetou, Maria, Marx, Nikolaus, Marx, Gernot, Simon, Tim-Philipp, Müller-Wieland, Dirk, Hartmann, Bojan, Kersten, Alexander, Müller, Tobias, Dreher, Michael
Publicado 2021

Efficacy and Safety of ELOM-080 as Add-On Therapy in COVID-19 Patients with Acute Respiratory Insufficiency: Exploratory Data from the Prospective Placebo-Controlled COVARI Trial

por Dreher, Michael, Grohè, Christian, Hartmann, Niels-Ulrik, Kanzler, Stephan, Kraft, Karin, Sarrazin, Christoph, Doll, Michael, Spiesshöfer, Jens, Steiner, Stephan, Wöhrle, Jochen, Seeger, Julia, Röschmann-Doose, Kristina, Thomsen, Jörn, Wittig, Thomas, Marx, Nikolaus, Eisenmann, Stephan
Publicado 2022

Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): a prospective, parallel group, randomised, controlled, open-label trial

por Bauer, Axel, Schreinlechner, Michael, Sappler, Nikolay, Dolejsi, Theresa, Tilg, Herbert, Aulinger, Benedikt A, Weiss, Günter, Bellmann-Weiler, Rosa, Adolf, Christian, Wolf, Dominik, Pirklbauer, Markus, Graziadei, Ivo, Gänzer, Hannes, von Bary, Christian, May, Andreas E, Wöll, Ewald, von Scheidt, Wolfgang, Rassaf, Tienush, Duerschmied, Daniel, Brenner, Christoph, Kääb, Stefan, Metzler, Bernhard, Joannidis, Michael, Kain, Hans-Ulrich, Kaiser, Norbert, Schwinger, Robert, Witzenbichler, Bernhard, Alber, Hannes, Straube, Florian, Hartmann, Niels, Achenbach, Stephan, von Bergwelt-Baildon, Michael, von Stülpnagel, Lukas, Schoenherr, Sebastian, Forer, Lukas, Embacher-Aichhorn, Sabine, Mansmann, Ulrich, Rizas, Konstantinos D, Massberg, Steffen
Publicado 2021